Old Zantac: what did the impurity tests show?

Tests found an impurity in some older ranitidine products. Heat and time mattered. A sample result does not show the dose you took or prove that the drug caused your cancer.

What is the impurity called NDMA?

NDMA is a chemical impurity that may form in ranitidine. FDA says it probably can cause cancer. That does not mean every user will get cancer.

The drug reduced stomach acid. FDA’s safety concern was about the impurity, including how it could change during storage. A hazard label does not identify a person’s exposure or diagnosis.

Did every tested pill have the same result?

No. FDA found different levels among selected products. Those samples do not tell you what was in every past bottle.

Keep the test method, sample and product date together when reading a number. The laboratory table is not a blood test or a record of how much impurity you swallowed.

Why did the test temperature matter?

FDA said high heat during testing can create more of the impurity. Its lower-heat method found lower levels. That did not clear all products of concern.

The October 2019 update criticized a method for this drug. FDA later acted on storage-related findings too. A method dispute and the eventual withdrawal are separate parts of the record.

Did a stomach model prove what happens in people?

No. FDA found no added impurity in its stomach-fluid model. That lab model is not a test of every person’s body.

It cannot establish your actual tablets, use or dose. Do not turn a model result into either a guarantee of safety or proof that a medicine caused a particular cancer.

What do studies of users show?

The studies have different findings. One found no clear overall cancer rise compared with other acid drugs. Another found higher rates for several cancers.

The 2023 study used eleven eligible databases, with a stricter primary comparison in four. The 2022 study had different comparison groups. Neither measured every user’s impurity exposure; other health factors and follow-up matter.

Does this describe the newly approved tablets too?

FDA approved new tablets in November 2025 after changes and tests. They use a new formula. The older withdrawal does not describe every later product.

Follow the actual product’s storage directions and discuss medicine choices with your clinician. The later approval does not decide whether an older product caused a past illness.